Consolidated Statements of Operations and Comprehensive Loss (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues	$ 0	$ 0
Operating expenses:
Research and development	102,825	121,106
General and administrative	99,249	139,011
Total operating expenses	202,074	260,117
Loss from operations	202,074	260,117
Other income expense:
Interest expense	323,170	396
Interest income	0	(6)
Change in fair value of derivative liability	352,807	0
Foreign current transaction loss (gain)	(70)	(256)
Total other expense	675,907	134
Net loss	(877,981)	(260,251)
Other comprehensive income (loss):
Foreign currency translations	(449)	(2,511)
Total comprehensive loss	$ (878,430)	$ (262,762)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00
Weighted average number of common shares outstanding - basic and diluted	415,699,254	378,033,149